Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;32(2):148-54.
doi: 10.1089/AID.2015.0296.

Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships

Affiliations

Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships

Andrew Mujugira et al. AIDS Res Hum Retroviruses. 2016 Feb.

Abstract

Background: Antiretroviral therapy (ART) markedly reduces the risk of HIV-1 transmission in serodiscordant partnerships. We previously found that younger age and higher CD4 counts were associated with delayed initiation of ART by HIV-1-infected partners in serodiscordant partnerships. Among those initiating ART, we sought to explore whether those same factors were associated with failure to achieve viral suppression.

Methods: In a prospective study of HIV-1-infected persons who had a known heterosexual HIV-1-uninfected partner in Kenya and Uganda [Partners Pre-Exposure Prophylaxis (PrEP) Study], we used Cox proportional hazards regression to evaluate correlates of viral nonsuppression (HIV-1 RNA >80 copies/ml).

Results: Of 1,035 HIV-1-infected participants initiating ART, 867 (84%) achieved viral suppression: 77% by 6 months and 86% by 12 months. Younger age [adjusted hazard ratio (aHR) 1.05 for every 5 years younger; p = .006], lower pretreatment CD4 count (aHR 1.26; p = .009 for ≤250 compared with >250 cells/μl), and higher pretreatment HIV-1 RNA quantity (aHR 1.21 per log10; p < .001) independently predicted failure to achieve viral suppression. Following initial viral suppression, 8.8% (76/867) experienced virologic rebound (HIV-1 RNA >200 copies/ml): 6.3% and 11.5% by 6 and 12 months after initial suppression, respectively. Age was the only factor associated with increased risk of virologic rebound (aHR 1.33 for every 5 years younger; p = .005).

Conclusions: For HIV-1-infected persons in serodiscordant couples, younger age was associated with delayed ART initiation, failure to achieve viral suppression, and increased risk of virologic rebound. Motivating ART initiation and early adherence is a key to achieving and sustaining viral suppression.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
Study profile. ART, antiretroviral therapy.
<b>FIG. 2.</b>
FIG. 2.
Time to first viral suppression following ART initiation.
<b>FIG. 3.</b>
FIG. 3.
Cumulative probability of virologic rebound following initial viral suppression.

Similar articles

Cited by

References

    1. Joint United Nations Programme on HIV/AIDS. The Gap Report.UNAIDS, Geneva, 2014
    1. Quinn TC, Wawer MJ, Sewankambo N, et al. : Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921–929 - PubMed
    1. Baeten JM, Kahle E, Lingappa JR, et al. : Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011;3:77ra29 - PMC - PubMed
    1. Cohen MS, Chen YQ, McCauley M, et al. : Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505 - PMC - PubMed
    1. Thompson MA, Aberg JA, Cahn P, et al. : Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010;304:321–333 - PubMed

Publication types

Substances